Leerink Partnrs Reduces Earnings Estimates for ICON Public

ICON Public Limited (NASDAQ:ICLR) – Research analysts at Leerink Partnrs cut their FY2025 earnings per share (EPS) estimates for shares of ICON Public in a research report issued on Tuesday, November 19th. Leerink Partnrs analyst M. Cherny now forecasts that the medical research company will post earnings of $14.11 per share for the year, down from their previous forecast of $14.58. Leerink Partnrs currently has a “Strong-Buy” rating on the stock. The consensus estimate for ICON Public’s current full-year earnings is $13.42 per share. Leerink Partnrs also issued estimates for ICON Public’s FY2026 earnings at $15.94 EPS and FY2027 earnings at $17.95 EPS.

Other analysts have also issued reports about the company. Leerink Partners restated an “outperform” rating and issued a $255.00 price target (down from $270.00) on shares of ICON Public in a report on Tuesday. JPMorgan Chase & Co. cut their target price on ICON Public from $375.00 to $280.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Evercore ISI decreased their price target on shares of ICON Public from $360.00 to $350.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Barclays cut their price objective on shares of ICON Public from $330.00 to $275.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Finally, Redburn Atlantic initiated coverage on shares of ICON Public in a research report on Monday, October 14th. They issued a “neutral” rating and a $311.00 target price for the company. Four investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $292.45.

ICON Public Price Performance

Shares of NASDAQ ICLR opened at $212.76 on Thursday. The company has a fifty day moving average price of $259.64 and a 200 day moving average price of $298.45. The firm has a market cap of $17.55 billion, a PE ratio of 23.72, a PEG ratio of 1.45 and a beta of 1.25. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. ICON Public has a 1-year low of $183.38 and a 1-year high of $347.72.

ICON Public (NASDAQ:ICLR) last announced its quarterly earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share for the quarter, missing analysts’ consensus estimates of $3.72 by ($0.37). ICON Public had a net margin of 9.00% and a return on equity of 11.91%. The company had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period in the previous year, the firm posted $3.10 EPS. The business’s quarterly revenue was down 1.2% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. EverSource Wealth Advisors LLC increased its holdings in shares of ICON Public by 17.4% in the first quarter. EverSource Wealth Advisors LLC now owns 283 shares of the medical research company’s stock valued at $95,000 after purchasing an additional 42 shares during the last quarter. Arkadios Wealth Advisors grew its stake in ICON Public by 5.0% in the 3rd quarter. Arkadios Wealth Advisors now owns 1,293 shares of the medical research company’s stock valued at $371,000 after buying an additional 62 shares during the last quarter. GAMMA Investing LLC grew its stake in ICON Public by 50.0% in the 2nd quarter. GAMMA Investing LLC now owns 261 shares of the medical research company’s stock valued at $82,000 after buying an additional 87 shares during the last quarter. Whittier Trust Co. of Nevada Inc. raised its holdings in ICON Public by 23.1% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 511 shares of the medical research company’s stock valued at $147,000 after acquiring an additional 96 shares during the period. Finally, WR Wealth Planners LLC lifted its position in ICON Public by 4.7% during the second quarter. WR Wealth Planners LLC now owns 2,359 shares of the medical research company’s stock worth $739,000 after acquiring an additional 105 shares during the last quarter. 95.61% of the stock is owned by institutional investors and hedge funds.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.